HARROWINC Trademark

Trademark Overview

On Monday, December 3, 2018, a trademark application was filed for HARROWINC with the United States Patent and Trademark Office. The USPTO has given the HARROWINC trademark a serial number of 88215102. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 22, 2022. This trademark is owned by IMPRIMIS PHARMACEUTICALS, INC.. The HARROWINC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ophthalmological use, for anesthesiological applications, for treating fibrotic diseases, for treating male sexual disorders, for treating skin disorders, for treating kidney stones, for treating nail disorders, for treating autoimmune diseases and cancer, and for treating bleeding
harrowinc

General Information

Serial Number88215102
Word MarkHARROWINC
Filing DateMonday, December 3, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 22, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements

Goods and ServicesPharmaceutical compositions for ophthalmological use, for anesthesiological applications, for treating fibrotic diseases, for treating male sexual disorders, for treating skin disorders, for treating kidney stones, for treating nail disorders, for treating autoimmune diseases and cancer, and for treating bleeding

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHARROW IP, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205
Party NameHARROW HEALTH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameHARROW HEALTH, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, August 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 22, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, January 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 27, 2022SOU EXTENSION 5 GRANTED
Tuesday, January 18, 2022SOU EXTENSION 5 FILED
Thursday, January 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 18, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 3, 2022ASSIGNED TO EXAMINER
Thursday, July 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 13, 2021SOU EXTENSION 4 GRANTED
Tuesday, July 13, 2021SOU EXTENSION 4 FILED
Tuesday, July 13, 2021SOU TEAS EXTENSION RECEIVED
Thursday, November 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 12, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 12, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 9, 2020SOU EXTENSION 3 GRANTED
Monday, November 9, 2020SOU EXTENSION 3 FILED
Monday, November 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2020SOU EXTENSION 2 GRANTED
Thursday, July 2, 2020SOU EXTENSION 2 FILED
Thursday, July 2, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020SOU EXTENSION 1 GRANTED
Monday, January 6, 2020SOU EXTENSION 1 FILED
Monday, January 6, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, November 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2019ASSIGNED TO LIE
Monday, April 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2019ASSIGNED TO EXAMINER
Wednesday, March 27, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, March 27, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 27, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, March 27, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 5, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, February 5, 2019PRIORITY ACTION E-MAILED
Tuesday, February 5, 2019PRIORITY ACTION WRITTEN
Wednesday, January 30, 2019ASSIGNED TO EXAMINER
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 6, 2018NEW APPLICATION ENTERED

Related Keywords

harrowinc treating disorders diseases kidney skin stones nail bleeding cancer autoimmune